24 May 2022 / Adam Ang / MobiHealth News
OncoRes medical device. (Supplied)
The company develops a breakthrough device for detecting residual cancer tissues.
Perth-based medical device firm OncoRes Medical has bagged $12.5 million in funding to support its upcoming clinical trials.
This article was first published by MobiHealth News. Click here for full article.